Next Article in Journal
The Non-Coding RNA Landscape of Plasma Cell Dyscrasias
Previous Article in Journal
HDAC6β€”an Emerging Target Against Chronic Myeloid Leukemia?
Previous Article in Special Issue
Effect of Estrogen Receptor Status on Circulatory Immune and Metabolomics Profiles of HER2-Positive Breast Cancer Patients Enrolled for Neoadjuvant Targeted Chemotherapy
Open AccessReview

Prognostic and Predictive Molecular Biomarkers for Colorectal Cancer: Updates and Challenges

1
Molecular Disease Mechanisms Group, Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine, University of Luxembourg, L-4367 Esch-sur-Alzette, Luxembourg
2
Centre Hospitalier Emile Mayrisch, Department of Oncology, L-4240 Esch-sur-Alzette, Luxembourg
*
Author to whom correspondence should be addressed.
Cancers 2020, 12(2), 319; https://doi.org/10.3390/cancers12020319
Received: 6 December 2019 / Revised: 20 January 2020 / Accepted: 22 January 2020 / Published: 30 January 2020
(This article belongs to the Collection Cancer Biomarkers)
Colorectal cancer (CRC) is a leading cause of death among cancer patients. This heterogeneous disease is characterized by alterations in multiple molecular pathways throughout its development. Mutations in RAS, along with the mismatch repair gene deficiency, are currently routinely tested in clinics. Such biomarkers provide information for patient risk stratification and for the choice of the best treatment options. Nevertheless, reliable and powerful prognostic markers that can identify “high-risk” CRC patients, who might benefit from adjuvant chemotherapy, in early stages, are currently missing. To bridge this gap, genomic information has increasingly gained interest as a potential method for determining the risk of recurrence. However, due to several limitations of gene-based signatures, these have not yet been clinically implemented. In this review, we describe the different molecular markers in clinical use for CRC, highlight new markers that might become indispensable over the next years, discuss recently developed gene expression-based tests and highlight the challenges in biomarker research. View Full-Text
Keywords: colorectal cancer; biomarkers; molecular markers; early stage CRC; gene signature; clinical transition; clinical test; challenges colorectal cancer; biomarkers; molecular markers; early stage CRC; gene signature; clinical transition; clinical test; challenges
Show Figures

Graphical abstract

MDPI and ACS Style

Koncina, E.; Haan, S.; Rauh, S.; Letellier, E. Prognostic and Predictive Molecular Biomarkers for Colorectal Cancer: Updates and Challenges. Cancers 2020, 12, 319.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop